Health Invest Partners Ab Pharvaris N.V. Transaction History
Health Invest Partners Ab
- $208 Million
- Q4 2024
A detailed history of Health Invest Partners Ab transactions in Pharvaris N.V. stock. As of the latest transaction made, Health Invest Partners Ab holds 34,328 shares of PHVS stock, worth $515,263. This represents 0.32% of its overall portfolio holdings.
Number of Shares
34,328
Previous 34,328
-0.0%
Holding current value
$515,263
Previous $635,000
3.62%
% of portfolio
0.32%
Previous 0.31%
Shares
1 transactions
Others Institutions Holding PHVS
# of Institutions
53Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$113 Million5.17% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$66 Million77.49% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$64.4 Million67.66% of portfolio
-
Viking Global Investors LP3.65MShares$54.8 Million0.24% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$49.6 Million17.1% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $507M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...